Sign inGet started

Alspaugh Jonathan

Insider CIK 1868112 · AGLE President and CFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AGLE Aeglea BioTherapeutics, In A Award deriv2023-06-222023-06-3019,787,969— $019,787,969SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2023-02-232023-02-24640,000— $0640,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2022-08-232022-08-25130,000— $0130,000SEC↗
AGLE Aeglea BioTherapeutics, In P Buy2022-03-112022-03-1575,000$2.08 $156.0K165,372SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2022-02-172022-02-22170,000— $0170,000SEC↗
AGLE Aeglea BioTherapeutics, In P Buy2021-12-092021-12-1350,000$3.72 $186.0K90,372SEC↗
AGLE Aeglea BioTherapeutics, In P Buy2021-08-182021-08-187,200$6.72 $48.4K40,372SEC↗
AGLE Aeglea BioTherapeutics, In P Buy2021-08-172021-08-1823,392$6.50 $152.0K33,172SEC↗
AGLE Aeglea BioTherapeutics, In P Buy2021-08-162021-08-189,780$6.37 $62.3K9,780SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2021-07-062021-07-08160,000— $0160,000SEC↗